With direct letters, regulatory comments and other activities, Vizient strives to form constructive relationships with lawmakers, regulatory agencies and administration officials, to provide a unified voice on issues that have a direct impact on our members.

2024 Advocacy

December 20 – Vizient comments on the Centers for Medicare & Medicaid Services (CMS) Information Collection Request (ICR) on implementation of the Medicare Drug Price Negotiation Program (MDPNP)

December 20 – Vizient comments to the Partnership for Quality Management (P4QM) on the 2024 Measures Under Consideration (MUC) list

October 24 – Vizient submits policy priority requests to congressional leadership for the remainder of the 118th Congress

October 14 - Vizient comments to EPA regarding Recommendations of Specifications, Standards and Ecolabels for Federal Purchasing

September 10 – Vizient joins over 300 industry stakeholders in letters to Congress and the White House urging a two-year extension of DEA telemedicine flexibilities

September 9 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the CY 2025 Physician Fee Schedule (PFS) Proposed Rule

September 9 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the CY 2025 Outpatient Prospective Payment System (OPPS) proposed rule

August 20 – Vizient comments to the Food and Drug Administration (FDA) on draft guidance “Considerations for Demonstrating Interchangeability with a Reference Product: Update”

August 16 – Vizient endorses the Health Workforce Innovation Act

August 2 – Vizient responds to bipartisan House request for information (RFI) on Next-Generation Cures legislation

July 2 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the Medicare Drug Price Negotiation Program: Draft Guidance, Implementation of Sections 1191 – 1198 of the Social Security Act for Initial Price Applicability Year 2027 and Manufacturer Effectuation of the Maximum Fair Price (MFP) in 2026 and 2027

June 28 - Vizient Urges U.S. Trade Representative Not to Finalize Tariffs on Imports of Medical Devices and Supplies from China – Cautioning of Potential Supply Disruptions

June 24 – Vizient endorsed coalition letter responding to the Senate Finance Committee Bipartisan Medicare Graduate Medical Education (GME) Working Group’s Draft Proposal Outline and Questions for Consideration

June 10 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the fiscal year (FY) 2025 Hospital Inpatient Prospective Payment System (IPPS) for Acute Care Hospitals and Quality Programs and Medicare Promoting Interoperability Program Requirements for Eligible Hospitals and Critical Access Hospitals proposed rule

May 29 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the Request for Information (RFI) on Medicare Advantage (MA) Data

May 16 - Vizient endorsed coalition letter calling for $758 million in FY 2025 funding for Children’s Hospital Graduate Medical Education (CHGME)

April 15 - Vizient comments to the Office of the National Coordinator (ONC) on United States Core Data for Interoperability (USCDI) Draft Version 5

April 11 - Vizient comments to the Centers for Medicare and Medicaid Services (CMS) on the “Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflict of Interest, and Related Provisions” proposed rule

April 1 – Vizient responds to the discussion draft of the Supporting Underserved and Strengthening Transparency, Accountability, and Integrity Now and for the Future of 340B Act (SUSTAIN 340B Act) and supplemental request for information (RFI)

March 14 - Vizient endorses the Mapping America’s Pharmaceutical Supply (MAPS) Act

February 22 – Vizient endorses the Assistance for Rural Community Hospitals (ARCH) Act

February 16 – Vizient endorses legislation to address patent thickets

February 13 – Vizient endorses the Affordable Prescriptions for Patients Act

January 24 – Vizient endorsed coalition letter in support of the Safety from Violence for Healthcare Employees (SAVE) Act

January 5 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) regarding Contract Year 2025 policy and technical changes to the Medicare Advantage (MA or Part C) and Medicare Prescription Drug Benefit (Part D) programs

January 2 – Vizient comments to the Centers for Medicare and Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC) on the “21st Century Cures Act: Establishment of Disincentives for Health Care Providers That Have Committed Information Blocking” proposed rule

Connect with Vizient to help you solve health care’s biggest challenges

Contact us